Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy : FFFirst report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial;Dreidimensionale konformale risikoadaptierte Radiotherapie des lokalisierten Prostatakarzinoms mit moderater Dosiseskalation von 70 auf 74 Gy. 5-Jahres-Resultate der prospektiven österreichisch-deutschen Phase-II-Multicenterstudie

Strahlentherapie und Onkologie

Volumn 185, Issue 2, 2009, Pages 94-100

  Goldner, Gregor ^a,g   Bombosch, Valentin ^a   Geinitz, Hans ^b   Becker, Gerd ^c   Wachter, Stefan ^a   Glocker, Stefan ^d   Zimmermann, Frank ^b   Wachter Gerstner, Natascha ^a   Schrott, Andrea ^e   Bamberg, Michael ^d   Molls, Michael ^b   Feldmann, Horst ^f   Pötter, Richard ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Hospital Am Eichert   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e Statistikambulanz ^*  (Austria)

^f KLINIKUM FULDA   (Germany)

^g MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

3D CRT; BNED; Outcome; Prostate cancer; Toxicity

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; GLEASON SCORE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PROSTATE CANCER; RADIATION DOSE; RADIATION INJURY; RISK ASSESSMENT; TREATMENT DURATION; TUMOR LOCALIZATION;

AGED; AGED, 80 AND OVER; AUSTRIA; DOSE FRACTIONATION; GERMANY; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RADIOTHERAPY, CONFORMAL; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 61349171229     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-009-1970-3     Document Type: Article

References (38)

1. American Society for Therapeutic RadiologyOncology Consensus Panel. 1997 Consensus statement: guidelines for PSA following radiation therapy Int J Radiat Oncol Biol Phys 37 1035 41
2. M.L. Cavey J.E. Bayouth M. Colman 2005 IMRT to escalate the dose to the prostate while treating the pelvic nodes Strahlenther Onkol 181 431 41
3. J.D. Cox J. Stetz T.F. Pajak 1995 Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1341 6
4. D.P. Dearnaley M.R. Sydes J.D. Graham 2007 Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial Lancet Oncol 8 475 87
5. G. De Meerleer L. Vakaet W. De Gersem 2004 Direct segment aperture and weight optimization for intensity-modulated radiotherapy of prostate cancer Strahlenther Onkol 180 136 43
6. B. Dobler S. Mai C. Ross 2006 Evaluation of possible prostate displacement induced by pressure applied during transabdominal ultrasound image acquisition Strahlenther Onkol 182 240 6
7. T.N. Eade A.L. Hanlon E.M. Horwitz 2007 What dose of external-beam radiation is high enough for prostate cancer? Int J Radiat Oncol Biol Phys 68 682 9
8. C. Fiorino G. Fellin T. Rancati 2008 Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study Int J Radiat Oncol Biol Phys 70 1130 7
9. E. Gershkevitsh C.H. Clark J. Staffurth 2005 Dose to bone marrow using IMRT techniques in prostate cancer patients Strahlenther Onkol 181 172 8
10. N. Gerstner S. Wachter D. Dorner 1999 Significance of a rectal balloon as internal immobilization device in conformal radiotherapy of prostatic carcinoma Strahlenther Onkol 175 232 8
11. A.L. Grosu M. Piert W.A. Weber 2005 Positron emission tomography for radiation treatment planning Strahlenther Onkol 181 483 99
12. M. Guckenberger M. Flentje 2007 Intensity-modulated radiotherapy (IMRT) of localized prostate cancer. A review and future perspectives Strahlenther Onkol 183 57 62
13. M. Guckenberger J. Meyer J. Wilbert 2007 Precision of image-guided radiotherapy (IGRT) in six degrees of freedom and limitations in clinical practice Strahlenther Onkol 183 307 13
14. P.J. Hoskin K. Motohashi P. Bownes 2007 High dose rate brachytherapy in combination with external beam radiotherapy in radical treatment of prostate cancer: initial results of a randomised phase three trial Radiother Oncol 84 114 20
15. ICRU. Report 62: Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50). Bethesda: International Commission on Radiation Units and Measurements; 1999.
16. B.A. Jereczek-Fossa A. Vavassori C. Fodor 2008 Dose escalation for prostate cancer using the three-dimensional conformal dynamic arc technique: analysis of 542 consecutive patients Int J Radiat Oncol Biol Phys 71 784 94
17. O. Koelbl F. Schwab K. Bratengeier 2005 Radiotherapy of prostate cancer with multileaf collimators (MLCs): optimization of the undulating dose distribution at the MLC edge Strahlenther Onkol 181 108 12
18. D.A. Kuban S.L. Tucker L. Dong 2008 Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer Int J Radiat Oncol Biol Phys 70 67 74
19. U. Mock J. Bogner D. Georg 2005 Comparative treatment planning on localized prostate carcinoma: conformal photon- versus proton-based radiotherapy Strahlenther Onkol 181 448 55
20. S.T.H. Peeters W.D. Heemsbergen P.C.M. Koper 2006 Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy J Clin Oncol 24 1990 6
21. A. Pollack A.L. Hanlon E.M. Horwitz 2004 Prostate cancer radiotherapy dose response: an update of the fox chase experience J Urol 171 1132 6
22. A. Pollack G. Zagars L.G. Smith 2000 Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer J Clin Oncol 18 3904 11
23. A. Pollack G.K. Zagars G. Starkschall 2002 Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 1097 105
24. J. Reibenwein 2005
25. M. Roach 3rd G. Hanks H. Thames Jr 2006 Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 65 965 74
26. M. Roach 3rd 2007 Dose escalated external beam radiotherapy versus neoadjuvant androgen deprivation therapy and conventional dose external beam radiotherapy for clinically localized prostate cancer: do we need both? Strahlenther Onkol 183 26 8
27. J.R. Sathaya I.R. Davis J.A. Julian 2005 Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate J Clin Oncol 23 1192 9
28. R.W. Schulte J.D. Slater C.J. Rossi 2000 Value and perspectives of proton radiation therapy for limited stage prostate cancer Strahlenther Onkol 176 3 8
29. W.U. Shipley L.J. Verhey J.E. Munzenrider 1995 Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone Int J Radiat Oncol Biol Phys 32 3 12
30. H.-K. Shu T.T. Lee E. Vigneault 2001 Toxicity following high-dose three-dimensional conformal and intensity-modulated radiation therapy for clinically localized prostate cancer Urology 57 102 7
31. F. Sterzing K. Schubert G. Sroka-Perez 2008 Helical tomotherapy. Experiences of the first 150 patients in Heidelberg Strahlenther Onkol 184 8 14
32. S. Wachter N. Gerstner G. Goldner 2001 Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factors Radiother Oncol 59 65 70
33. E.E. Yeoh R. Holloway R.J. Fraser 2006 Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: updated results of a phase III randomized trial Int J Radiat Oncol Biol Phys 66 1072 83
34. M.J. Zelefsky H. Chan M. Hunt 2006 Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer J Urol 176 1415 9
35. M.J. Zelefsky S.A. Leibel P.B. Gaudin 1998 Dose escalation with three dimensional conformal radiation therapy affects the outcome in prostate cancer Int J Radiat Oncol Biol Phys 41 491 500
36. M.J. Zelefsky E.J. Levin M. Hunt 2008 Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 70 1124 9
37. M.J. Zelefsky J. Moughan J. Owen 2004 Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 patterns of care survey for prostate cancer Int J Radiat Oncol Biol Phys 59 1053 61
38. A.L. Zietman M.L. DeSilvio J.D. Slater 2005 Comparison of conventional-dose vs. high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial JAMA 294 1233 9